secwatch.observer — SEC 8-K summary
======================================

Issuer:     CorMedix Inc. (CRMD)
CIK:        0001410098
Form:       8-K
Filed at:   2022-10-17T23:59:59+00:00
Accession:  0001213900-22-064356
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CorMedix stockholders elect directors and approve all four proposals at 2022 annual meeting
--------------------------------------------------------------------------------

- Seven director nominees elected (Costa, Dillione, Duncan, Dunton, Kaplan, Lefkowitz, Todisco) with for votes ranging from 7.6M to 9.2M; 19.1M broker non-votes.
- Advisory vote on executive compensation approved: 8,041,682 for, 2,406,462 against, 123,127 abstain.
- Amendment and restatement of 2019 Omnibus Stock Incentive Plan approved: 8,110,236 for, 2,308,931 against.
- Ratification of Friedman LLP as independent auditor for FY2022 approved: 27,961,029 for, 1,579,888 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410098/000121390022064356/0001213900-22-064356-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410098/000121390022064356/ea167215-8k_cormedixinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-064356

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer